Today: 7 February 2026
Subscribe
Browse Category

Oil Industry News 6 January 2026 - 9 January 2026

SLB stock up in premarket as White House Venezuela meeting keeps oil-services trade in play

SLB stock up in premarket as White House Venezuela meeting keeps oil-services trade in play

SLB shares rose about 1% in U.S. premarket trading Friday, after closing up 4.9% at $44.43, as the White House readies talks with oil firms on Venezuela. Vitol received a preliminary U.S. license to negotiate Venezuelan oil deals, sources said. Oil prices remained subdued, with U.S. crude at $55.99 a barrel Wednesday. SLB reports earnings Jan. 23, with analysts expecting $0.74 per share.
9 January 2026
··
Chevron stock jumps after hours as Venezuela licence talks put CVX back in play

Chevron stock jumps after hours as Venezuela licence talks put CVX back in play

Chevron shares rose 2.6% to $159.25 in after-hours trading Thursday after reports of talks with Washington to expand its Venezuela license. U.S. officials have invited Vitol and Trafigura executives to discuss Venezuelan oil sales Friday. Brent crude settled up 3.4% at $61.99 a barrel. Chevron’s Venezuelan exports fell to about 100,000 bpd in December after tighter U.S. terms.
9 January 2026
··
Exxon stock jumps after Q4 upstream warning; oil rebound and Jan. 30 earnings loom

Exxon stock jumps after Q4 upstream warning; oil rebound and Jan. 30 earnings loom

Exxon Mobil shares rose 3.7% in after-hours trading after a filing warned of a possible $0.8–$1.2 billion hit to Q4 upstream earnings from weaker crude prices. The company cited stronger refining margins as a potential offset. Investors are watching for Exxon’s Jan. 30 earnings and Friday’s U.S. jobs report. Oil prices surged over 3% Thursday amid global supply concerns.
9 January 2026
···
Oil stocks slide before the open as Exxon flags up to a $1.2 billion hit — what to watch next

Oil stocks slide before the open as Exxon flags up to a $1.2 billion hit — what to watch next

Exxon Mobil dropped 2.1% and ConocoPhillips fell 3.3% in U.S. premarket trading after Exxon warned lower crude prices could cut Q4 upstream earnings by up to $1.2 billion. Brent crude edged up 6 cents to $60.02 a barrel, but analysts warned of a potential 3 million bpd surplus in early 2026. U.S. crude stocks fell 3.8 million barrels, while gasoline and distillate inventories jumped.
8 January 2026
·····
Chevron stock price forecast: CVX slips as $22 bln Lukoil bid talk and Venezuela oil control jolt the outlook

Chevron stock price forecast: CVX slips as $22 bln Lukoil bid talk and Venezuela oil control jolt the outlook

Chevron shares fell 0.9% to $155.17 after reports it may join a bid for Lukoil’s international assets. U.S. officials signaled plans to control Venezuelan oil sales “indefinitely,” as Chevron continues exports from the country. Brent crude dropped 1.3% to $59.94. The company’s next earnings call is set for January 30.
7 January 2026
···
DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

DHT Holdings shares jumped 6.6% to $12.81 in New York as U.S. officials moved to allow Venezuelan crude imports and ease some sanctions. Oil prices slipped, with Brent down 0.7% at $60.31 a barrel. The U.S. Coast Guard seized a Russian-flagged tanker linked to Venezuelan oil after a two-week pursuit. Investors tracked signs of cargo rerouting and upcoming U.S. oil inventory data.
7 January 2026
·····
Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil shares fell 1.1% to $119.71 Wednesday as oil prices dropped after President Trump said Venezuela would send up to 50 million barrels of sanctioned oil to the U.S. Brent crude slipped 0.7% to near $60 a barrel. Exxon is set to release a fourth-quarter “earnings considerations” 8-K after market close. Trump plans to meet oil executives later this week to discuss Venezuela.
7 January 2026
··
Frontline (FRO) stock jumps as Venezuela tanker seizures stir oil-shipping bets

Frontline (FRO) stock jumps as Venezuela tanker seizures stir oil-shipping bets

Frontline shares jumped 7.7% to $23.27 by late morning Wednesday as U.S. authorities seized a Venezuela-linked tanker reflagged under Russia, spurring a rally in tanker stocks. DHT Holdings, International Seaways, Teekay Tankers, and Scorpio Tankers also posted gains. Investors focused on freight rates, which have surged amid sanctions and vessel shortages. Oil prices fell after President Trump announced new Venezuelan crude shipments to the U.S.
7 January 2026
·
UK stocks today: FTSE 100 retreats from record highs as BP, Shell slide on Venezuela oil deal

UK stocks today: FTSE 100 retreats from record highs as BP, Shell slide on Venezuela oil deal

FTSE 100 fell 0.5% by mid-morning Wednesday, led by declines in BP and Shell as oil prices dropped after a reported U.S.-Venezuela supply deal. Topps Tiles rose 1.5% on higher revenue. UK construction activity shrank for a 12th month, with the PMI at 40.1. Investors shifted into utilities and property stocks after Tuesday’s record close.
7 January 2026
····
Phillips 66 buys UK Lindsey oil refinery assets — but says it won’t reopen the plant

Phillips 66 buys UK Lindsey oil refinery assets — but says it won’t reopen the plant

Phillips 66 Limited will acquire assets from the closed Lindsey Oil Refinery and integrate key facilities into its Humber Refinery, keeping Lindsey offline as a crude-processing site. The Insolvency Service named Phillips 66 as the successful bidder, with the sale subject to regulatory approval. Lindsey, shuttered since July, once produced 10% of UK fuel. The company has not disclosed the sale price or long-term job plans.
7 January 2026
··
Exxon Mobil (XOM) stock slips after Venezuela-fueled rally as investors weigh oil supply risks

Exxon Mobil (XOM) stock slips after Venezuela-fueled rally as investors weigh oil supply risks

Exxon shares dropped 1.4% to $123.63 Tuesday morning, reversing part of Monday’s gains as traders weighed U.S. talks on boosting Venezuelan oil output. Brent crude rose 0.7% to $62.22 a barrel. Chevron fell 2.7%, while ConocoPhillips was flat. The S&P 500 energy index had hit a 10-month high Monday after U.S. military action in Venezuela.
6 January 2026
···
Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

The Ibovespa closed up 0.83% at 161,869.76 on Monday, led by gains in Vale and banks, while Petrobras fell despite a jump in oil prices after U.S. moves on Venezuela. Trading volume reached R$24.9 billion. The dollar slipped to near R$5.40. Investors are watching the new Ibovespa portfolio and executive changes at GPA and IMC ahead of Brazil’s inflation data on Jan. 9.
6 January 2026
··
1 … 3 4 5 6 7 … 11

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop